persistent atrial fibrillation
Conditions
Interventions
treatment group:During cardiac surgery, experimental instruments are used to perform concomitant ablation for atrial fibrillation
Sponsors
Guangdong Provincial People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 80, with no gender preference 2. Planned cardiac surgery (including valve replacement or repair surgery, coronary artery bypass surgery, etc.) 3. Persistent atrial fibrillation (AF) (AF duration =7 days) 4. Agree to participate in this study and voluntarily sign the informed consent form
Exclusion criteria
Exclusion criteria: 1. Previously underwent cardiac surgical maze procedure 2. Requiring emergency cardiac surgery (such as cardiogenic shock) 3. Intra-aortic balloon counterpulsation or intravenous cardiotonic agents are required before surgery 4. Left ventricular ejection fraction (LVEF) =6 cm 6. Cardiac functional classification (NYHA) class IV 7. Equipped with one or multiple pulmonary vein stents, or implanted with an implantable cardioverter defibrillator, pacemaker, or any other implantable electronic devices 8. Patients with systemic active infection who, according to the researchers' judgment, are unable to undergo surgical treatment 9. Renal failure patients with obvious bleeding tendency who cannot undergo surgery or are undergoing hemodialysis 10. Patients who have experienced acute myocardial infarction within 6 weeks five 11. Patients who have experienced a stroke (excluding lacunar infarction) or transient ischemic attack within the past 6 months 12. Patients with obvious surgical contraindications or an expected survival period of less than 1 year 13. Women who are pregnant or breastfeeding, or who have family planning during the study period 14. Patients who have participated in other drug or medical device clinical trials within 3 months 15. Patients whom researchers consider unsuitable for participation in this clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Success rate of treatment at 6 months post-surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Effective treatment rate at 6 months after surgery;Antiarrhythmic reintervention rate at 6 months after surgery;Device performance evaluation; | — |
Countries
China
Contacts
Public ContactGuo Huiming
Guangdong Provincial People's Hospital
Outcome results
None listed